Fundz

Who to call at Solventum Corporation, and when

Fundz watches for the moments Solventum Corporation starts buying, and tells you who to reach.

  • An alert the day Solventum Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Solventum Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Solventum Corporation. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral

Solventum Corporation

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

www.solventum.com
Filed: Oct 21, 2025Saint Paul, MinnesotaCIK: 0001964738Health Care
Full company profileView on SEC.gov

2 executive changes at Solventum in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.

See every company with multiple executive changes →

AI Executive Summary

AI-powered analysis of 8-K filing content

Solventum appointed Heather Knight, formerly COO at Baxter, to the newly created role of Chief Commercial Officer, effective November 10, 2025, overseeing global commercial and R&D operations across MedSurg, Dental Solutions, and Health Information Systems. Chris Barry, EVP and Group President of MedSurg, departs December 31, 2025, with severance under the Solventum Executive Severance Plan.

Key Takeaways

Heather Knight, who has over 30 years of MedTech leadership experience and most recently served as COO at Baxter, becomes Chief Commercial Officer effective November 10, 2025.

The CCO role is newly created and consolidates global commercial and R&D operations across the MedSurg, Dental Solutions, and Health Information Systems segments under one executive.

3 more takeaways

Related Filings (8)

8 more filings from Solventum Corporation in the last 90 days

Filing Overview

Form Type8-K
Filing DateOct 21, 2025
Item5.02
CategoryExecutive Change
CIK0001964738
Accession #0001628280-25-045731
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
executive hireexecutive departureleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

Solventum Corporation filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.